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SUMMARY
We investigated the circadian timing of intestinal regeneration
using the null mutant BMAL1. Our results show that the
circadian clock regulates the timing of inﬂammation and
proliferation during regeneration.
BACKGROUND & AIMS: The gastrointestinal syndrome is an
illness of the intestine caused by high levels of radiation. It is
characterized by extensive loss of epithelial tissue integrity, which
initiates a regenerative response by intestinal stem and precursor
cells. The intestine has 24-hour rhythms in many physiological
functions that are believed to be outputs of the circadian clock: a
molecular system that produces24-hour rhythms in transcription/
translation. Certain gastrointestinal illnesses are worsened when
the circadian rhythms are disrupted, but the role of the circadian
clock in gastrointestinal regeneration has not been studied.
METHODS: We tested the timing of regeneration in the mouse
intestine during the gastrointestinal syndrome. The role of the
circadian clock was tested genetically using the BMAL1 loss of
function mouse mutant in vivo, and in vitro using intestinal
organoid culture.
RESULTS: The proliferation of the intestinal epithelium follows
a 24-hour rhythm during the gastrointestinal syndrome. The
circadian clock runs in the intestinal epithelium during this
pathologic state, and the loss of the core clock gene, BMAL1,
disrupts both the circadian clock and rhythmic proliferation.
Circadian activity in the intestine involves a rhythmic produc-
tion of inﬂammatory cytokines and subsequent rhythmic acti-
vation of the JNK stress response pathway.
CONCLUSIONS: Our results show that a circadian rhythm in
inﬂammation and regeneration occurs during the gastrointestinal
syndrome. The study and treatment of radiation-induced illnesses,
andothergastrointestinal illnesses, should consider24-hour timing
in physiology and pathology. (Cell Mol Gastroenterol Hepatol
2017;4:95–114; http://dx.doi.org/10.1016/j.jcmgh.2017.03.011)
Keywords: Intestine; Circadian Rhythms; Gastrointestinal
Syndrome; TNF; Intestinal Stem Cells.
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The intestinal epithelium can produce cells at a pro-digious rate, and a long-standing question in the
ﬁeld is what mechanisms underlie its regeneration following
damage or stress. The epithelium is maintained by a popu-
lation of stem cells that divide to produce transit-amplifying
precursors, differentiated enterocytes, goblet cells, Paneth
cells, and enteroendocrine cells.1 Stem cells and precursors
are localized to the base of the crypts of Lieberkühn, and
their progeny differentiate as they move upward toward the
villus. The use of radiation to damage the epithelium and
initiate a regenerative response is an important and clini-
cally relevant model to study regeneration in the small
intestine.2,3
High levels of radiation induce the gastrointestinal syn-
drome,4–6 an illness associated with the loss of dividing
precursors and stem cells during the ﬁrst 24 hours, and
breakdown of the epithelial barrier, which leads to increased
permeability, infection, and extensive inﬂammation.6 This is
then followed by a regenerative response initiated from a
surviving population of stem cells. Understanding the
mechanisms underlying the gastrointestinal syndrome pro-
vides essential insight into intestinal regeneration, with the
potential for impacting patients exposed to ionizing radiation.
The timing of the molecular and cellular mechanisms, or
chronobiology, of the gastrointestinal syndrome is poorly
understood. In general, the importance of intestinal chro-
nobiology is somewhat underappreciated, although 1 form
of timing, its circadian rhythms, has been studied exten-
sively.7 Circadian rhythms are biologic processes that occur
with an approximate cycle of 24 hours. They are driven by a
highly conserved molecular pacemaker, called the circadian
clock, which produces 24-hour rhythms in animal behavior
and physiology.8 An example of a circadian rhythm is an
animal’s locomotor activity; when the clock is disrupted,
activity becomes arrhythmic.9
In mammals, the circadian clock consists of the trans-
activators CLK and BMAL1 (also called ARNTL) and their
negative regulators PER1-3 and CRY1-2.8,10 The transcrip-
tional targets of CLK/BMAL1 include PER1-3 and CRY1-2,
which accumulate as proteins during the night to repress
their own expression. A second form of transcriptional con-
trol is driven by RORa andREV-ERBa (also calledNR1D1) that
activate and repress BMAL1 expression, respectively. Post-
transcriptional and posttranslational mechanisms also
contribute to rhythmicity.11 Photoperiod, ingested food, and
hormone levels synchronize circadian clocks throughout the
body to drive 24-hour transcriptional rhythms with charac-
teristic maxima and minima at speciﬁc times of day. A
tremendous number of processes throughout the body are
inﬂuenced by the circadian clock. For example, more than
40%of the genome is expressed rhythmically, and in different
tissues 3%–16%of these genes are rhythmic, and include key
rate-limiting enzymes.12 Previous studies have shown that
circadian transcriptional rhythms are present in the digestive
tract,13–16 but their function has not been tested.
Circadian rhythms are important in human health and, in
particular, inﬂuence several digestive system illnesses. Shift-
workers undergo photoperiod disruption and experience
higher rates of gastrointestinal pain,17 ulcers,18 and colo-
rectal cancer.19 Experimental models also reveal that colitis
is worsened during photoperiod disruption,20 highlighting a
possible connection between circadian rhythms and intes-
tinal inﬂammation. The response to gastrointestinal injury is
also time-dependent: patients with cancer treated with
radiotherapy have more severe intestinal mucositis when
irradiated in the morning versus in the evening.21 These
studies show that digestive tract physiology changes ac-
cording to time of day, and that disruption to this timing has
negative consequences.
Although circadian rhythms are widespread throughout
the body, the circadian timing system is hierarchical.22 A
circadian clock in the suprachiasmatic nucleus of the hy-
pothalamus receives light input from the retina to syn-
chronize it to the daily light/dark (LD) cycle. Even in the
absence of light input, the suprachiasmatic nucleus gener-
ates rhythms in body temperature, food intake, and hor-
mone levels that synchronize circadian clocks in other
tissues, such as the intestine, which normally receive syn-
chronizing information originating in the brain. To what
extent does the intrinsic clock in the intestine regulate the
regenerative response? Despite data showing circadian
rhythms in the intestine and the immune system, studies of
gastrointestinal disease do not consider time-of-day effects.
To address this fundamental question we investigated
the timing of intestinal regeneration in the epithelium of
mice with the gastrointestinal syndrome, and found
diurnal rhythms in crypt cell proliferation. We next
investigated the role of the core circadian clock gene,
BMAL1, in the intestine before and after acute radiation
injury. Regeneration in this tissue is BMAL1-dependent,
which regulates daily timing of the JNK stress response
pathway activity and subsequent proliferation. Our data
suggest that cytokines, which are rhythmically expressed
in the intestine during regeneration, drive a circadian
stress response in the epithelium. By regulating the stress
response, BMAL1 promotes the 24-hour rhythmic pro-
duction of intestinal epithelia. These data shed light on the
importance of the circadian clock during intestinal illness
and regeneration.
Materials and Methods
Animal Housing
BMAL1þ/þ and BMAL1-/- mouse littermates were bred
from BMAL1þ/- parents (Jackson Laboratories, Bar Harbor,
ME #009100), and were housed on a 12-hour light/12-hour
dark photoperiod with ad libitum food. We use the term
diurnal, rather than circadian, in the text because all of our
experiments were performed on a LD photoperiod, rather
than in the absence of circadian entrainment factors. All
mice were maintained according to animal care regulatory
approval at Boston Children’s Hospital (#A07 09 124R),
University of Massachusetts Medical School (#A-1315), or
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the University of Windsor (#AUPP 14-21). Gamma irradia-
tion was performed at Zeitgeber time (ZT) 3 at 1.05 Gy/min
for a total of 12 Gy in 1 single treatment, and animals were
returned to 12-hour light/12-hour dark photoperiod with
ad libitum food, and Bactrim antibiotic (Hi Tech Pharmacal,
Amityville, NY) in drinking water following treatment. In-
testinal tissues were sampled from irradiated mice, or
control (undamaged) animals housed under the same LD
photoperiod conditions, at Day 4, for 24 hours following
irradiation. A total of 3–4 mice were examined per condition
(normal conditions vs irradiation, genotype, time point).
Both female and male mice were included in the study,
because no signiﬁcant sex-linked differences were found in
all of the parameters examined in this study.
Intestinal Tissues
Animals were humanely euthanized using CO2 at 4-hour
time points over a day: ZT0, ZT4, ZT8, ZT12, ZT16, and
ZT20 as indicated in Figures 1–9. For data shown in
Figure 1B, tissue was collected at Day 0, 1, 2, 3, 4, and 5 at
ZT4. Samples of proximal intestine (10 cm of small intes-
tine containing duodenum and a portion of the jejunum)
were collected for analysis. Samples were ﬂushed clean
using 4 mM sodium phosphate buffer pH7.4 þ 155 mM
saline (phosphate-buffered saline [PBS]). Each 10-cm
sample was further cut into 4–5 segments. A w0.5-cm
portion of each 2-cm segment was collected in RNAlater
buffer (Qiagen, Toronto, Ontario, Canada) and stored at
-80C for RNA puriﬁcation. The remaining w1.5-cm seg-
ments of intestine were ﬁxed in 4% paraformaldehyde
(Electron Microscopy Sciences, Hatﬁeld, PA) þ PBS over-
night at 4C for immunoﬂuorescence and histology.
RNA Puriﬁcation and Analysis
In vivo tissue was homogenized in RLT Buffer (Qiagen)
using a Bullet Blender (Next Advance, Averill Park, NY)
according to the manufacturer’s protocol. Organoids (see
later) were lysed directly into RLT Buffer and vortexed until
the solution was homogenous. RNA was puriﬁed using the
RNEasy Mini RNA puriﬁcation kit (Qiagen), and RNA was
then transcribed to cDNA using the iScript RT Supermix
(Bio-Rad, Mississauga, Ontario, Canada) according to the
manufacturer’s protocols.
Quantitative Polymerase Chain Reaction
cDNA levels were quantiﬁed using the iTaq Universal
SYBR Green Supermix (Bio-Rad) on a Viia7 real-time poly-
merase chain reaction system (Thermo Fisher Scientiﬁc).
From 3–4 samples were examined per genotype, at each
time point or condition (see previous sections for details of
tissue collection and RNA puriﬁcation). Primer sequences
were obtained from PrimerBank, and ampliﬁed at w90%
efﬁciency. The primers used are shown in Table 1.
Immunoﬂuorescence and Histochemistry
Following ﬁxation, intestinal tissues were washed in PBS
three times and immersed in 30% sucroseþ PBS overnight at
4C to cryoprotect. Tissuesweremounted in Tissue-TekO.C.T
compound (Sakura, Flemingweg, Netherlands) and sectioned
at 10-mm thickness on a cryostat. Slides containing tissue
sections were washed 3 times for 5 minutes at room tem-
perature with PBS. Organoids were stained in 1.5-mL
microcentrifuge tubes following ﬁxation. Samples were
blocked using 5% normal goat serum (Thermo Scientiﬁc,
Toronto, Ontario, Canada) in PBS þ 0.3% Triton-X100
(Fisher, Toronto, Ontario, Canada) for 1 hour. Primary anti-
body was applied overnight (anti-Villin 1:1000, anti
Lysozyme 1:1000, anti-CCL2 1:75 [Abcam, Toronto, Ontario,
Canada ab130751, ab108508, ab8101, respectively]; anti-
Ki67 1:500 [Vector Labs VP-RM04]; anti-Phospho-Histo-
neH3 [Ser 10] 1:1000 [Upstate/Millipore, Etobicoke, Ontario,
Canada 06-570]; anti-Per2 1:200 [Millipore AB5428P]; anti–
nuclear factor kB [NFkB] 1:400, anti-Phospho-c-Jun S73
1:800 [Cell Signaling Technology B14E12, D47G9, respec-
tively]; anti-GFP 1:2000 [Nacalai Tesque Inc., Kyoto, Japan
GF090R]; anti-cleaved Caspase3 1:200 [Cell Signaling Tech-
nology 9661s] in 1.2% normal goat serum at 4C overnight.
Sections were washed in PBS 3 times for 5 minutes followed
by incubation in Alexa 488, or Alexa 555 (Life Technologies,
Toronto, Ontario, Canada) secondary antibodies for 1 hour
(1:2000), and counterstained with DAPI or TOPRO3 nuclear
stains (Life Technologies) in 1.2%normal goat serum at room
temperature. Sections were then washed 3 times for 5 mi-
nutes in PBS at room temperature and mounted using Pro-
long Antifade Gold (Invitrogen, Toronto, Ontario, Canada).
Antigen retrieval was performed for CCL2, Lysozyme, NFkB,
and Ki67 using sodium citrate buffer þ 0.5% Tween for 10
minutes at 109C, 1.7 PSI. Antigen retrieval was performed
for PER2, GFP, and Phospho-c-Jun using 1% sodium dodecyl
sulfate for 10minutes at room temperature. EdU stainingwas
done using the Click iT EdU Alexaﬂuor 555 kit according to
manufacturer’s instructions (Thermo Scientiﬁc). Alcian blue
(EMS) staining was done at 30 minutes, room temperature.
The sectionswerewashed under runningwater for 2minutes
then immediately rinsed with distilled water. The sections
were then counterstained with Nuclear Fast Red (EMS) for 5
minutes at room temperature. Sections were dehydrated in
95% ethanol 2 times for 5 minutes at room temperature,
followed by another dehydration step with 100% ethanol 2
times for 5 minutes at room temperature. Sections were
cleared using Histo-clear (EMS) 2 times for 10 minutes at
room temperature, andmounted in Clearium (EMS). A total of
3–4 samples were examined per condition (normal condi-
tions versus irradiation, genotype, time point).
Microscopy and Quantiﬁcation
Organoid images were taken using a Keyence BZ9000
microscope. Intestinal tissue sections were imaged using
either a Olympus Fluoview FV-1000 confocal microscope
or a Zeiss LSM780 confocal microscope. Images were
processed using Adobe Photoshop CS5. Antibody-positive
cells were quantiﬁed as the total number of labeled cells/
total number of DAPIþ nuclei present in a crypt section.
Twenty crypts were sampled per animal for the quantiﬁ-
cation of Ki67, phosphorylated histone H3 (pHH3),
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phosphorylated c-JUN (pJUN), Caspase3, or FUCCI re-
porters, with 3–4 animals/organoid lines examined per
condition. Paneth cells were quantiﬁed as the number of
lysozyme-positive cells per crypt in 30 crypts sampled
from 3 animals of each genotype. Goblet cells were quan-
tiﬁed as the number of alcian blue–positive cells in 10 villi
ﬁeld of views (20 objective) per animal from 3 animals of
each genotype. Crypts were counted by sampling 10
regions of 1 mm from 6 animals of each genotype. Quan-
tiﬁcation of data shown in Figures 1B, 2A, 3A, and 3C was
done at the time point ZT4.
Statistics
Statistical analysis was carried out using Student’s t test
to compare genotype differences (Figures 1A, 2A, 3A, 3D,
Figure 1. Cell proliferation exhibits a diurnal rhythm during the gastrointestinal syndrome. (A) Crypts exhibit changes
following irradiation (IR), during the gastrointestinal syndrome (4 days after IR). Hematoxylin-eosin staining shows villus
morphology is disrupted, and crypts are less abundant, larger, and hyperplastic. (B) Proliferation and cell death timing over 5
days following IR was assessed in the morning. After injury, proliferation (marked by antiphosphorylated Histone H3 mitoses)
increases, whereas cell death (marked by anticleaved Caspase3 apoptosis) decreases. (C) In the control (nonirradiated) state,
crypt nuclei number is constant (P ¼ .3669). Each data point represents the average of 1 animal (20 crypts sampled). ZT on the
x-axis refers to the time lights turn on (ZT0) and off (ZT12). (D) Following IR, the number of cells increases over 36 hours
between Days 4 and 6 of healing (F ¼ 10.53; P < .0001). This is likely a result of increased proliferation as the epithelium repairs
itself from IR damage. (E) Mitoses in the control (nonirradiated) are constant without signiﬁcant differences over time (P ¼
.2909). (F) During the gastrointestinal syndrome (IR), mitoses exhibit a strong diurnal rhythm with signiﬁcant differences at
different times (F ¼ 11.32; P < .0001). Mitoses peak at approximately ZT0-4 over both days. Each data point represents the
average of 1 animal (20 crypts sampled), and the solid line indicates the average of these.
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and 7C), 1-way analysis of variance to compare differences
in time (Figures 1B–E, 3B, 4A, 4C, 5B, 6A, 6B, and 7B), and 2-
way analysis of variance to compare difference in both ge-
notype and time (or genotype and expression levels)
(Figures 2D, 3B, 3C, 4A, 4C, 5B, 5D, 6A–C, 7B, 9A, and 9B). All
statistics were done using Prism 5.0 software (Graphpad
Software Inc). Results are indicated in legends; error bars
show standard error of the mean.
Figure 2. A BMAL1-dependent diurnal rhythm is present during intestinal regeneration 4–5 days after injury. (A)
Hematoxylin-eosin staining shows both BMAL1þ/þ and BMAL1-/- intestines are adversely affected during the gastrointestinal
syndrome (compare with Figure 1A). The BMAL1-/- epithelium contains signiﬁcantly fewer crypts (P ¼ .0272). (B) Mitosis in the
BMAL1þ/þ and -/- epithelium is marked by pHH3. Images show confocal stacks (merged) from 10-mm sections. (C) Cell
proliferation (marked by Ki67, which labels cells in S/G2/M phases) is present in the irradiated (IR) intestine of both genotypes.
Insets below ﬁrst row of images show higher magniﬁcation of crypts that are proliferating. Images show single confocal
sections of intestinal crypts. (D) The IR BMAL1þ/þ crypt has a diurnal rhythm in mitoses with signiﬁcant differences at different
times (F ¼ 7.30; P ¼ .0002). There are signiﬁcant differences in mitoses between the BMAL1þ/þ and the BMAL1-/- crypt (F ¼
19.07; P ¼ .0002). BMAL1-/- intestinal precursors proliferate arrhythmically and at a lower level overall than BMAL1þ/þ. Bottom
panels show that mitoses vary in both the lower half of crypts (transit-amplifying and stem cell region), and the upper half of
crypts (transit-amplifying cell region). The ﬁrst 24 hours of BMAL1þ/þ data are replotted from Figure 1F. (E) Cell death (marked
by cleaved Caspase3, which labels cells undergoing apoptosis) shows no signiﬁcant time-of-day differences in BMAL1þ/þ
(P ¼ .5046), or differences between BMAL1þ/þ and BMAL1-/- (P ¼ .1072).
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Organoid Culture
Intestinal organoids were prepared and cultured from in-
testinal tissues of BMAL1þ/þ, BMAL1-/-, BMAL1þ/þ;FUCCI2þ/-,
BMAL1-/-;FUCCI2þ/-, and PER2-Luciferase mice using estab-
lished methods.23 For timed RNA collection, and Luciferase
experiments, organoids were passaged and grown for 3–4
Figure 3. Loss of BMAL1 produces no overt intestinal phenotypes in uninjured mice. (A) At 3 months of age the intestinal
epithelium of BMAL1-/- mice resembles that of BMAL1þ/þ littermates. Hematoxylin-eosin staining shows similar crypt and
villus morphology, although there is a signiﬁcant difference in the number of crypts present (P ¼ .0076). (B) Mitoses in the
BMAL1þ/þ undamaged crypt epithelium show no signiﬁcant diurnal variation (P ¼ .2909), and there are no signiﬁcant dif-
ferences between BMAL1þ/þ and BMAL1-/- (P ¼ .6842). The ﬁrst 24 hours of BMAL1þ/þ data is replotted from Figure 1E. (C)
Quantiﬁcation of cell type markers by real-time quantitative polymerase chain reaction at ZT4 (n ¼ 4 mice per genotype) shows
no signiﬁcant differences (P ¼ .7412) in the expression of intestinal epithelial genes (CDH1, VIL1, LYZ1), and intestinal epithelial
precursor and stem cell marker genes (OLFM4, LRIG1, ATOH1, LGR5). (D) The BMAL1þ/þ and BMAL1-/- epithelium shows the
same number of goblet cells (alcian blue), enterocytes (VIL), and Paneth cells (LYZ) as shown by the presence of these
cell-type markers. Brightﬁeld images were taken using conventional microscopy, ﬂuorescence images are confocal stacks
(merged) from 10-mm sections taken. The number of Paneth cells, and goblet cells, is not signiﬁcantly different between the 2
genotypes (P ¼ .2528 and P ¼ .7950, respectively).
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Figure 4. The intestinal epithelium displays a BMAL1-dependent circadian rhythm during normal homeostasis and
during regeneration. (A) The BMAL1þ/þ intestine of animals on a standard 12-hour light/12-hour dark photoperiod shows
rhythms in clock gene expression: PER2 (F ¼ 7.267; P ¼ .0055), BMAL1 (F ¼ 30.67; P < .0001), and REV-ERBa (F ¼ 18.33;
P ¼ .0002). BMAL1-/- animals do not show these rhythms: PER2 (P ¼ .7839), BMAL1 (P ¼ .6397), and REV-ERBa (P ¼ .6880).
Expression of the gene TBP (TATA Binding Protein) has no rhythm in either genotype. There are signiﬁcant differences
between genotypes in PER2 (F ¼ 3.41; P ¼ .0242), BMAL1 (F ¼ 219.0; P < .0001), and REV-ERBa (F ¼ 87.27; P < .0001). (B)
PER2 protein is present in the undamaged intestinal precursors (crypts are outlined to indicate the region where precursors are
located). PER2 is present in higher levels at ZT16–20, and shows nuclear localization in the epithelial cells of the crypt at these
times. At ZT0–8, expression is weaker and predominantly cytoplasmic. Images show single confocal sections of intestinal
crypts. (C) The 24-hour rhythm in clock gene expression 4 days after irradiation is similar to the undamaged intestine, but at
lower levels relative to GAPDH. The gene TBP is not affected by the clock, or stress, and has no circadian rhythm. There are
signiﬁcant differences between genotypes in PER2 (F ¼ 120.8; P < .0001), BMAL1 (F ¼ 225.7; P < .0001), and REV-ERBa
(F ¼ 74.65; P < .0001). IR, irradiation.
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days, then pulsed with 100 nM dexamethasone (Sigma) for 1
hour. Dexamethasone media was then replaced with fresh
media. For RNA sampling, organoids were collected at 4-hour
intervals from 0–28 hours (time is indicated in ﬁgures), by
lysing directly into RLT buffer (Qiagen) with 1% b-mercap-
toethanol. Figure 5D organoid RNA was collected from un-
synchronized organoids, collected before passaging and
untreated with dexamethasone. Bioluminescence recordings
were performed after dexamethasone treatment, by adding
Luciferin (Gold Biotechnologies) to organoid media at a ﬁnal
concentration of 0.1 mM and monitoring cultures for light
output at 15-minute intervals using a Hamamatsu LM2400
bioluminescence recorder andHamamatsu LM2400 software
version 12. For tumor necrosis factor (TNF) experiments,
organoids were grown for 6–8 days, then media containing
10 ng/mL recombinant TNF (Life Technologies), or 10 ng/mL
recombinant TNF togetherwith 100 ng/mL function blocking
TNF antibody (R&D Systems, Minneapolis, MN), was applied
for the indicated times (see ﬁgures). Organoids were not
synchronized using dexamethasone in Figures 5D or 7, and
“untreated” are organoids given newmedia (but with no TNF
or anti-TNF) and collected at 24 hours. For staining and
immunoﬂuorescence, organoids were separated from
Matrigel using Cell Recovery Solution (Corning, Canada) for
30 minutes on ice, and ﬁxed for 1.5 hours in 4% PFA (EMS).
For irradiation experiments (Figure 5E), organoids (unsyn-
chronized/not treatedwith dexamethasone)were exposed to
X-ray radiation at Day 3 of culture, at 0–8 Gy, then assayed by
CellTiter Glo assay (Promega, Madison, WI) for cell number 4
days later. In all organoid experiments, 3–4 samples were
examined per condition (genotype, and/or time point).
Western Blotting
Organoids were separated from Matrigel by incubating
in Cell Recovery Solution (Corning) on ice for 30 minutes,
supernatant was removed, and samples were lysed in RIPA
buffer containing Pierce Protease and Phosphatase Inhibitor
(Pierce, Toronto, Ontario, Canada). Electrophoresis was
carried out on PAGEr EX Gels (Lonza, Basel, Switzerland)
and Western blotted on PVDF (Thermo Scientiﬁc). Westerns
were blocked 30 minutes with 5% milk in PBS-T 0.1%
Triton X100. Primary antibodies were incubated overnight
at 4C: anti-Ki67 1:1000 (Abcam ab15580), anti-pJun S73
1:2000 (Cell Signaling Technology D47G9), and anti-
Tubulin 1:5000 (Sigma). Secondary antibodies were incu-
bated for 1 hour at room temperature: Dk anti-Rabbit-HRP
or anti-Mouse-HRP 1:10000 (Jackson ImmunoResearch
711-35-152, 715-035-15, respectively). HRP was developed
using Super Signal Femto (Thermo Scientiﬁc) and imaged
on a FluorChem E Gel Imager (Protein Simple, San Jose, CA).
Three samples were examined for each genotype at all time
points indicated in the ﬁgures.
Results
Timing of Cell Death and Proliferation During the
Gastrointestinal Syndrome
When intestinal cells are damaged and die, stem and
precursor cells divide to replace cells and return the
epithelium to its original state. Intuitively, this process
would be facilitated if cells were produced as quickly as
possible. To explore the timing of epithelial cell replace-
ment, we investigated the small intestine of mice after high-
dose (12 Gy) irradiation (Figure 1A). The number of
proliferating cells was assessed using antibody to pHH3,
which labels cells undergoing mitosis, and the number of
dying cells was assessed using antibody to cleaved Cas-
pase3, which labels cells undergoing apoptosis. Immediately
following irradiation, proliferation is very low, then sharply
increases as crypts disintegrate 1 day later (Figure 1B). We
could not distinguish between proliferating epithelial cells
or those from adjacent tissues, such as the blood system,
because 1 day after irradiation the epithelium is highly
morphologically disorganized. However, after this time
epithelial proliferation gradually increases as crypts reap-
pear and grow to regenerate the epithelium. These data are
consistent with previous reports that have shown epithelial
repair occurs several days after damage by irradiation.6,24 In
contrast to proliferation, apoptosis peaks 1 day after irra-
diation, but then decreases to low levels when crypts are
proliferating (Figure 1B). We focused our investigation on
4–5 days following irradiation, when proliferation is at high
levels and apoptosis is at lower levels.
The regenerating small intestine of mice with the gastro-
intestinal syndrome was compared with the intestine of un-
irradiated control animals. Analysis of overall crypt number
showed a marked decrease during the gastrointestinal syn-
drome compared with control animals (13.3 ± 0.7 crypts per
mm vs 23.2 ± 0.9 crypts per mm; Student’s t test; P< .0001),
presumably caused by extensive cell death from radiation.5
However, unlike crypts in undamaged intestines whose cell
number remains constant over the course of 24 hours
(Figure 1C), the surviving crypts during the gastrointestinal
syndrome are hyperplastic (Figure 1D), suggesting an
increased rate of proliferation in response to damage.
To assess themitotic index, we quantiﬁed the percentage of
pHH3-positive nuclei relative to the total number of crypt
nuclei present. During the gastrointestinal syndrome, the in-
testine shows a higher mitotic incidence than in control mice
(Figures 1E and F), conﬁrming the tissue is undergoing rapid
regeneration. The nonirradiated intestine shows 2% mitotic
cells in crypts over the course of 24 hours. Strikingly, the rate of
mitoses during the gastrointestinal syndrome demonstrates a
diurnal rhythm: the mitotic index at its peak is 5%–7% (ZT4)
and at its lowest is 2%–3% (ZT12). This diurnal pattern of
peaks and troughs repeats itself with a 24-hour period
(Figure 1F), and mitoses are present in the upper and lower
regions of the crypt suggesting that circadian regulation occurs
in the stem cell and transit-amplifying cell populations. These
results are consistent with studies published >40 years ago
reportingdaily variability in intestinal cell proliferation,25,26 but
which are now overlooked in studies of intestinal regeneration.
BMAL1 Is Required for Diurnal Proliferation
Rhythms During the Gastrointestinal Syndrome
The circadian clock functions in nearly all cells of the
body, including the stomach,15 intestine,14 and colon.13,15 In
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Figure 5. The intestinal epithelium has a clock. (A) Intestinal organoids were established from both BMAL1þ/þ and -/- intestines.
Phase-contrast images are shown in brightﬁeld. (B)BMAL1þ/þ organoids show circadian rhythms in clock gene expression:PER2 (F¼
46.41;P< .0001),BMAL1 (F¼ 38.41;P< .0001),REV-ERBa (F¼ 46.10;P< .0001), andCRY1 (F¼ 15.96;P¼ .0009). The control gene
TBP does not show such rhythms but rather a gradual decrease following dexamethasone synchronization. There are signiﬁcant dif-
ferencesbetweengenotypes inPER2 (F¼ 5.21;P¼ .0387),BMAL1 (F¼ 866.6;P< .0001),REV-ERBa (F¼ 556.8;P< .0001), andCRY1
(F ¼ 32.17; P < .0001). (C) Organoids were established from 3 separate PER2-Luc intestines and luminescence readings show that
rhythms in transcriptional clockactivity persist for several days (1 representative tracing is shown). (D) Cellularmarkers in unsynchronized
organoids quantiﬁed by real-time quantitative polymerase chain reaction show that BMAL1-/- intestinal organoids have decreased
expressionofCDH1 (P¼ .0148),VIL1 (P¼ .0223),LYZ1 (P¼ .0498), andLGR5 (P¼ .0149) expression. (E) Thenumberof viable organoid
cells (CellTiter Glo assay) is equivalent between BMAL1þ/þ and BMAL1-/- organoids, 4 days after varying doses of X-ray irradiation (as
indicated in the graph). The intestinal epithelium has no signiﬁcant BMAL1-dependent differences in sensitivity to radiation (P¼ .5310).
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these gastrointestinal tissues, the clock has been proposed
to play a key role in digestion and homeostasis7,16; however,
its role in intestinal regeneration has not been studied
genetically in mammals. We therefore investigated the core
clock gene, BMAL1, using BMAL1-/- mutant mice that are
viable but have a complete loss of circadian clock function.9
BMAL1-/- mice have been shown to display signs of pre-
mature ageing, hence we performed all of our studies using
mice at 12–15 weeks of age before ageing and other
health-related phenotypes have been observed.27 BMAL1þ/þ
and BMAL1-/- littermate mice were housed on a 12-hour
light/12-hour dark photoperiod to test the role of BMAL1
in regeneration.
During the gastrointestinal syndrome both BMAL1þ/þ
and BMAL1-/- intestines lose their characteristic
morphology, and BMAL1-/- crypts show a w10% decrease
in abundance relative to BMAL1þ/þ (Figure 2A). Regener-
ating crypts of both genotypes are highly proliferative, as
Figure 6. The regenerative response inﬂuences the 24-hour rhythms of genes. (A) WEE1 shows diurnal variability in the
undamaged intestine, with signiﬁcant differences between BMAL1þ/þ and BMAL1-/- (F ¼ 8.04; P ¼ .0005). CCND1 and CCL2
expression are similar in both genotypes, whereas TNF exhibits 24-hour variability in the undamaged BMAL1þ/þ intestine, but
none in the BMAL1-/- (F ¼ 15.99; P ¼ .0008). (B) During the gastrointestinal syndrome (IR), WEE1 is arrhythmic (P ¼ .7382),
but CCND1 displays high and low periods of expression over 24 hours. These are not likely a function of the circadian clock,
but rather a response to environmental changes (eg, feeding), because the BMAL1-/- mutant also shows the same pattern,
albeit at a signiﬁcantly lower level (F ¼ 16.04; P ¼ .0006). CCL2 exhibits a BMAL1-dependent circadian rhythm (F ¼ 4.318;
P ¼ .0176), as does TNF (F ¼ 4.204; P ¼ .0221). There are signiﬁcant differences between genotypes in CCL2 (F ¼ 7.13; P ¼
.0137) and TNF (F ¼ 7.66; P ¼ .0109). Increased levels of TNF are present in BMAL1-/- mice at ZT4, whose levels are otherwise
lower at all times compared with BMAL1þ/þ. It is only at this time point that expression is elevated, suggesting that TNF
production in the absence of BMAL1 may be a response to an environmental cue (eg, feeding). (C) BMAL1þ/þ organoids show
no rhythms inWEE1 or CCL2 expression (compare with the control gene TBP in Figure 5B); however, TNF is expressed with a
24-hour rhythm in BMAL1þ/þ but not BMAL1-/- organoids (F ¼ 10.45; P ¼ .0060). This suggests that only TNF is regulated by
the clock in intestinal epithelial cells. IR, irradiation.
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marked by the presence of antibody to pHH3, which labels
cells in M-phase (Figure 2B), and Ki67, which labels cells in
G1/S/G2/M-phases (Figure 2C). In contrast to the
BMAL1þ/þ regenerating intestine, the mitotic index in the
regenerating BMAL1-/- intestine does not show a diurnal
rhythm (Figure 2D). Signiﬁcant differences in mitosis are
present between the BMAL1þ/þ and BMAL1-/- intestine,
with the latter showing a lower mitotic index and
arrhythmic cell production. However, unlike these prolif-
eration differences, apoptosis is equivalent between the 2
genotypes and is not rhythmic (Figure 2E). These data
show that diurnal, BMAL1-dependent changes in prolifer-
ation occur in the epithelium during the gastrointestinal
syndrome, and that the loss of BMAL1 causes a small
decrease in overall crypt number.
BMAL1 Is Not Required During Intestinal Tissue
Maintenance in Uninjured Mice
We next tested whether intestinal cell production is
BMAL1-dependent under normal, undamaged conditions.
The loss of BMAL1 produced no obvious differences in in-
testinal crypt or villus morphology; however, a slight but
signiﬁcant decline in the number of crypts was noted
(Figure 3A). This result is consistent with recent ﬁndings
that the PER1/PER2 double mutant also has a slight
decrease in crypt number.28 The BMAL1-related difference
in baseline crypt number may explain the overall reduction
in the number of crypts following irradiation (Figure 2A).
In the absence of radiation damage, we found no signiﬁ-
cant diurnal variation in mitoses in the BMAL1þ/þ intestine,
and no signiﬁcant differences between BMAL1þ/þ and
Figure 7. The circadian
clock regulates JNK
signaling. (A) CCL2 che-
mokine is expressed het-
erogenously in epithelial
cells including LYZþ Pan-
eth cells (arrows in top row
of images), and crypt pre-
cursors (epithelial cells
within crypt shown in mid-
dle row of images), as well
as blood cells that are
likely monocytes or mac-
rophages that, like Paneth
cells, all coexpress LYZ
(cells outside of crypts
denoted by arrowheads).
Images show confocal
stacks (merged) from 10-
mm sections taken at ZT4
(crypts are outlined). (B)
The NFkB transcription
factor does not show sig-
niﬁcant nuclear accumula-
tion at any time point over
24 hours (ZT8 is shown as
an example), in either ge-
notype, suggesting it is not
regulated by the circadian
clock. (C) pJUN shown by
its nuclear localization (ar-
rows) is higher in BMAL1þ/
þ crypts at ZT16–20 during
the gastrointestinal syn-
drome. Although pJUN
shows variability between
crypts and within crypt
cells, overall the BMAL1-/-
intestine shows less activ-
ity at all times. Images
show confocal stacks
(merged) from 10-mm sec-
tions. Quantiﬁcation of the
percentage of pJUNþ crypt
cells is indicated in the in-
dividual panels.
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Figure 8. The circadian clock regulates proliferation timing in the intestinal epithelium. (A) Representative Western blots
from 3 organoid lines examined per genotype (outer black lines indicate separate blots). BMAL1þ/þ intestinal organoids show a
JNK signaling response to TNF at 0.5 hours (pJUN), which is absent when organoids are treated with anti-TNF inhibitor. TNF
treated BMAL1þ/þ organoids are proliferative (Ki67), but this is also reduced by anti-TNF. BMAL1-/- organoids show a JNK
(pJUN) response to TNF, but their proliferation (Ki67) is initially very high compared with BMAL1þ/þ. (B) BMAL1þ/þ organoids
exhibit a TNF-dependent upregulation of P21 expression (F ¼ 36.85; P ¼ .0007), with an initial increase at 4 hours followed by
a sharp decrease at 8 hours (Tukey multiple comparisons test shown). BMAL1-/- do not show this pattern, and anti-TNF
treatment of BMAL1þ/þ organoids results in an increase rather than decrease in P21 expression over time. There are
signiﬁcant differences in P21 between these genotypes/conditions (F ¼ 4.061; P ¼ .0033). Expression of the JUN target gene,
CCND1, is signiﬁcantly lowered by anti-TNF in BMAL1þ/þ organoids over time (F ¼ 9.865; P ¼ .0017) but does not vary
signiﬁcantly between BMAL1þ/þ and BMAL1-/- organoids (P ¼ .6678). (C) S-phase (marked by EdU uptake) is higher in
BMAL1-/- organoids 4 hours after TNF treatment, consistent with their lower level of P21 at this time (Student’s t test
comparison is shown). Untreated organoids (media change only) show no such differences (P ¼ .7811). (D) The FUCCI cell
cycle reporter shows that BMAL1þ/þ organoids have greater numbers of crypt cells in G1-phase compared with BMAL1-/-
organoids, 4 hours after TNF induction. Pie charts show the percentage of crypt cells in each phase, in the corresponding
genotypes; there are signiﬁcantly more G1 cells in BMAL1þ/þ compared with BMAL1-/- (Student’s t test, P ¼ .0020).
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BMAL1-/- (Figure 3B). The absence of such rhythms in
maintenance conditions is consistent with studies that re-
ported no daily variation in intestinal cell production,29,30
predating subsequent studies that reported a circadian
rhythm.25,26
To assess the impact of BMAL1 loss on cell lineage
development, intestine cell-speciﬁc markers were examined
via quantitative real-time polymerase chain reaction
between BMAL1þ/þ and BMAL1-/- mice. No signiﬁcant dif-
ferences in expression levels between the genotypes was
found, suggesting that the epithelial cell lineage is intact
when BMAL1-/- is absent (Figure 3C). However, we did note
that LGR5 and OLFM4, both markers of a crypt base stem
cell population,1 are slightly lower in BMAL1-/-. No obvious
differences in morphology or distribution in goblet cells,
enterocytes, or Paneth cells were noted (Figure 3D), sug-
gesting that the production of differentiated cells in the
BMAL1-/- intestine is unaffected under baseline conditions.
We further quantiﬁed Paneth cells and goblet cell numbers,
and conﬁrmed there were no signiﬁcant differences be-
tween the BMAL1þ/þ and BMAL1-/- intestine (Figure 3D).
We conclude that under maintenance conditions, the loss of
BMAL1 does not disrupt intestinal epithelial tissue renewal.
Circadian Clock Activity Persists During Stress
The intestine has been reported to exhibit 24-hour
rhythms in clock gene expression,14 hence we investigated
the expression of circadian clock genes in the intestine of
BMAL1þ/þ and BMAL1-/- littermate mice. Consistent with
previous reports,13–16,31 the undamaged intestine of
BMAL1þ/þ mice exhibits a diurnal expression pattern of
PER2, BMAL1, and REV-ERBa (Figure 4A). The sinusoidal,
rhythmic expression proﬁles are consistent with rhythms
seen in other mouse tissues, with BMAL1 expression
peaking at ZT20, approximately antiphase to the time of
peaks of PER2 (ZT8-12) and REV-ERBa (ZT8).32 The
BMAL1-/- intestine shows no rhythms in the expression of
these genes under the same conditions, conﬁrming the
clock is dysfunctional when BMAL1 is absent. The gene TBP,
which is not clock-regulated,33 shows no rhythms in either
genotype under LD photoperiod.
Figure 9. Equivalent gene
expression in intestinal
organoid culture. (A)
BMAL1þ/þ, BMAL1-/-, and
BMAL1þ/þ organoids treated
with anti-TNF show similar
expression of the JNK target
gene CD44 (P ¼ .8363). (B)
BMAL1-/- organoids show
similar expression of the cell
cycle regulators CCNB1 (P ¼
.5970), CCNE1 (P ¼ .4307), C-
MYC (P ¼ .7082), and E2F
(P ¼ .8220) when stimulated
with TNF.
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We next examined PER2 protein in intestinal crypts by
immunoﬂuorescence over a 24-hour time span (Figure 4B).
PER2 protein is rhythmically expressed under circadian
clock regulation, in many tissues, with a peak abundance
that typically lags behind maximal transcript levels by 4–6
hours.34 In the intestine, PER2 is expressed at higher levels
during the night (ZT16-20), in the crypts where prolifer-
ating intestinal stem cells and transit-amplifying cells reside.
To assess if the circadian clock continues to function
during the pathologic state of the gastrointestinal syndrome,
we tested the expression of BMAL1, PER2, and REV-ERBa
transcripts. These clock genes exhibit diurnal rhythms in
BMAL1þ/þmice that peak at times similar to the undamaged
intestine, but are reduced in levels relative to GAPDH
(Figure 4C). Thus, the circadian clock is intact during the
intestinal regenerative response, and shows similar activity
timing as during normal conditions (Figure 4A). These data
suggest that the gastrointestinal syndrome does not reset
the phase of the intestinal clock.
Circadian Clock Regulates Intestinal Organoid
Gene Expression
The intestine contains epithelium, muscle, nerves, blood
cells, and connective tissues, and the clock transcripts
detected in our samples (Figures 3C, 4A, and 4C) may be
expressed by any of these cells. Previous circadian studies
have relied on similar sampling methods,15,16 or have
enriched for differentiated epithelial cells by scraping them
from the surrounding tissues.13,14 Although scraping
enriches for epithelial genes, samples may contain non-
epithelial cell RNA. To speciﬁcally assess the circadian
clock in the intestinal epithelium, we established pure
epithelial cell cultures using intestinal stem cells from
BMAL1þ/þ and BMAL1-/- mice to generate organoids
(Figure 5A).23
Organoids were treated with a 1-hour pulse of dexa-
methasone to synchronize their clocks,33 resulting in rhyth-
mic expression of the clock genes BMAL1, PER2, CRY1, and
REV-ERBa (Figure 5B). BMAL1þ/þ intestinal organoids show
clock gene expression patterns (Figure 5B) that strongly
resemble those in vivo (Figure 4), whereas BMAL1-/- do not,
suggesting that the intestinal epithelium contains a functional
circadian system that requires BMAL1. The control gene TBP
is not rhythmic in organoids, and displays a gradual decrease
in expression over this time. We further conﬁrmed that in-
testinal organoids express tissue-autonomous circadian
rhythms by examining bioluminescence rhythms in organoids
derived from PER2-Luciferase mice.35 Per2-Luciferase orga-
noids show circadian rhythms that persist for >4 days
following synchronization (Figure 5C). These results are
consistent with recent reports using organoid culture,28,36
which support that the intestinal epithelium has a tissue-
autonomous, BMAL1-dependent circadian clock.
We next reexamined the expression of cell-speciﬁc
markers to test the consequence of BMAL1 loss in orga-
noid culture. We examined organoids before dexamethasone
synchronization, and compared BMAL1þ/þ and BMAL1-/- at
Table 1.List of Primer Sequences
Target Forward primer Reverse primer
ATOH1 GAGTGGGCTGAGGTAAAAGAGT GGTCGGTGCTATCCAGGAG
BMAL1 TGACCCTCATGGAAGGTTAGAA GGACATTGCATTGCATGTTGG
CCL2 TTAAAAACCTGGATCGGAACCAA GCATTAGCTTCAGATTTACGGGT
CCND1 GCGTACCCTGACACCAATCTC CTCCTCTTCGCACTTCTGCTC
CCNE1 GTGGCTCCGACCTTTCAGTC CACAGTCTTGTCAATCTTGGCA
CD133 CCTTGTGGTTCTTACGTTTGTTG CGTTGACGACATTCTCAAGCTG
CD44 TCGATTTGAATGTAACCTGCCG CAGTCCGGGAGATACTGTAGC
CDH1 TCGGAAGACTCCCGATTCAAA CGGACGAGGAAACTGGTCTC
C-MYC ATGCCCCTCAACGTGAACTTC GTCGCAGATGAAATAGGGCTG
CRY1 CACTGGTTCCGAAAGGGACTC CTGAAGCAAAAATCGCCACCT
E2F GAGAAGTCACGCTATGAAACCTC CCCAGTTCAGGTCAACGACAC
GAPDH AGGTCGGTGTGAACGGATTTG TGTAGACCATGTAGTTGAGGTCA
LGR5 CCTACTCGAAGACTTACCCAGT GCATTGGGGTGAATGATAGCA
LRIG1 TTGAGGACTTGACGAATCTGC CTTGTTGTGCTGCAAAAAGAGAG
LYZ1 GAGACCGAAGCACCGACTATG CGGTTTTGACATTGTGTTCGC
OLFM4 CAGCCACTTTCCAATTTCACTG GCTGGACATACTCCTTCACCTTA
P21 CCTGGTGATGTCCGACCTG CCATGAGCGCATCGCAATC
PER2 GAAAGCTGTCACCACCATAGAA AACTCGCACTTCCTTTTCAGG
REV-ERBa TGAACGCAGGAGGTGTGATTG GAGGACTGGAAGCTATTCTCAGA
TBP AGAACAATCCAGACTAGCAGCA GGGAACTTCACATCACAGCTC
TNF CCCTCACACTCAGATCATCTTCT GCTACGACGTGGGCTACAG
VIL1 TCAAAGGCTCTCTCAACATCAC AGCAGTCACCATCGAAGAAGC
WEE1 GAAACAAGACCTGCCAAAAGAA GCATCCATCTAACCTCTTCACAC
108 Stokes et al Cellular and Molecular Gastroenterology and Hepatology Vol. 4, No. 1
1 time point (Figure 5D). Quantitative real-time polymerase
chain reaction showed that BMAL1-/- organoids have lower
expression of the differentiated genes CDH1, VIL1, and LYZ1,
as well as LGR5, a marker of intestinal precursor and stem
cells. These deﬁciencies suggest that the production or
function of epithelial cells is autonomously reduced in the
intestinal epithelium, when BMAL1 is absent. To further test
cell production in organoids, we examined cell number in
organoids in normal conditions, and 4 days following
exposure to 1, 4, or 8 Gy X-irradiation. There were no sig-
niﬁcant BMAL1-dependent differences in organoid cell
number assayed following irradiation damage (Figure 5E).
Our results are consistent with previous ﬁndings that the
circadian clock does not regulate cell survival in vitro
following irradiation.37
Cell Cycle Regulators Are Arrhythmic
During Regeneration
Cell division often exhibits a 24-hour cycle but how or
whether it is linked to the circadian clock is a matter of long-
standing research.10 Two cell cycle regulators, WEE1 and
CCND1, have been previously implicated as clock tar-
gets,38,39 and we therefore hypothesized that these might
drive rhythms in cell proliferation during the gastrointes-
tinal syndrome.
WEE1 is a direct CLK/BMAL1 target in the liver, where it
represses the G2-M phase transition.38 In the undamaged
BMAL1þ/þ intestine, WEE1 expression has a diurnal rhythm
(peak is ZT8-12), consistent with previous reports,14 and its
expression in BMAL1-/- animals is arrhythmic, suggesting
clock control (Figure 6A). However, at this time point
mitoses are not actually rhythmic (Figure 3B). During the
gastrointestinal syndrome, WEE1 expression is arrhythmic
(Figure 6B), despite the strong diurnal rhythm in mitosis
present (Figure 2D). This suggests WEE1 rhythms are
decoupled from proliferation rhythms in this tissue, hence,
we further tested whether the intestinal epithelial clock
regulates WEE1 autonomously using organoid culture.
Despite possessing circadian clock activity (Figures 5B and
C), BMAL1þ/þ organoids do not exhibit rhythms in WEE1
gene expression (Figure 6C).
CCND1 (CyclinD) is regulated by CLK/BMAL1 in
osteoblasts, where it enables the G1-S phase transition.40
CCND1 is arrhythmic in both the BMAL1þ/þ and BMAL1-/-
intestine under normal conditions (Figure 6A), but exhibits
24-hour variation during the gastrointestinal syndrome
(Figure 6B). This daily pattern of CCND1 expression is similar
in both the BMAL1þ/þ and BMAL1-/- intestine, suggesting it is
not regulated by the circadian clock. Taken together, these
data suggest that neitherWEE1 nor CCND1 link the clock and
the cell cycle in the intestinal epithelium. We therefore sought
to investigate other mechanisms that could shed light on how
the epithelium proliferates with a circadian rhythm.
Cytokine Production Is Rhythmic
During Regeneration
The immune system has circadian rhythms41,42 as
evidenced by its highly variable time-of-day-dependent
response to infection,43,44 its susceptibility to photoperiod
disruption,45 and clock regulation of cytokine
production.42–44 Inﬂammation is likely to affect intestinal
physiology during the gastrointestinal syndrome, and
recently it has been shown that the innate immune system
coordinates circadian rhythms between the microbiota and
the intestinal epithelium.46 We therefore examined whether
inﬂammation during the gastrointestinal syndrome regu-
lates intestinal cell production. The immune system pro-
duces many factors whose rhythmic expression could drive
circadian processes in the epithelium. We tested the
expression of several cytokines (TNF, IL6, IL10, IL17B, IL22,
and CCL2), some of which have been previously implicated
in the circadian biology of the immune system.41–43
CCL2, a chemokine that recruits monocytes to regions of
infection and injury, is not expressed with diurnal variation
in the undamaged intestine (Figure 6A), but shows diurnal
changes during the gastrointestinal syndrome in BMAL1þ/þ
but not in BMAL1-/- (Figure 6B). The TNF cytokine displays
diurnal variation in BMAL1þ/þ intestines during normal
conditions, and is arrhythmic and lower in BMAL1-/-
(Figure 6A). During the gastrointestinal syndrome, the
BMAL1þ/þ intestine exhibits diurnal changes in TNF. These
are altered in BMAL1-/- animals, which show a single sharp
peak at ZT4, but otherwise remain lower than BMAL1þ/þ at
all other times (Figure 6B). These results suggest that TNF
and CCL2 exhibit clock-dependent expression during the
gastrointestinal syndrome. The interleukin genes we
examined (IL6, IL10, IL17B, and IL22) did not show any
diurnal BMAL1-dependent changes under the 2 conditions
examined.
We tested whether TNF and CCL2 are produced by the
intestinal epithelium. TNF is known to be expressed in
intestinal epithelial cells,47 and BMAL1þ/þ organoids exhibit
24-hour rhythms in TNF that are absent in BMAL1-/- orga-
noids, suggesting it is a clock target in the epithelium
(Figure 6C). CCL2 is not expressed with a rhythm in orga-
noid culture (Figure 6C), suggesting its rhythmic expression
in vivo is not caused by the epithelium. This was further
tested by antibody staining in irradiated animals, where
CCL2 was expressed by cells that stained positively for the
marker LYZ, suggesting these were monocytes or macro-
phages (Figure 7A). CCL2 was also expressed in the
epithelium at ZT4 in both epithelial precursors and Paneth
cells where it is has been shown to be induced by TNF.48
These results suggest that CCL2 is produced by both the
epithelium and resident white blood cells, but that epithelial
cells are not responsible for CCL2 diurnal rhythms during
the gastrointestinal syndrome.
BMAL1 Regulates the Tumor Necrosis
Factor Response
TNF is an inﬂammatory cytokine, which can signal
through both NFkB and c-JUN transcription factors.49 These
pathways have been recently implicated in intestinal pro-
liferation: sustained activity of NFkB50 or JNK51 leads to
hyperplasia and tumorigenesis. We tested the activity of the
TNF pathway by staining for NFkB and pJUN over a 24-hour
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time course, 4 days following radiation injury. NFkB is
predominantly cytoplasmic in the crypt cells of both
BMAL1þ/þ and BMAL1-/- mice, suggesting that NFkB is not
active under these conditions (Figure 7B). In contrast, pJUN
has a higher nuclear signal in the proliferating crypts of
BMAL1þ/þ mice at ZT16, during the gastrointestinal syn-
drome, but is lower at other times (Figure 7C). BMAL1-/-
crypts show lower signal and no diurnal variation over 24
hours. This suggests JNK signaling is regulated by the
circadian clock during the gastrointestinal syndrome, either
through rhythmic production of TNF by the surrounding
myeloid cells42 or from epithelial cells themselves
(Figure 6C).
Signaling between intestinal epithelial and nonepithelial
cells is a very complex dynamic. Hence we tested whether
BMAL1 regulates the epithelial response to TNF using in-
testinal organoids, which contain only epithelial cells. Both
BMAL1þ/þ and BMAL1-/- organoids have an immediate
response to TNF, which causes an increase in pJUN levels
0.5 hours after stimulation (Figure 8A). Function-blocking
anti-TNF antibody completely abolishes the pJUN response
in BMAL1þ/þ organoids conﬁrming this is a TNF-dependent
process. We next examined a possible link between TNF
signaling and proliferation. BMAL1þ/þ organoids are pro-
liferative (Ki67 positive) before and after TNF-stimulation,
suggesting TNF does not reduce epithelial proliferation
during inﬂammation. In contrast, Ki67 is initially much
higher in BMAL1-/- organoids and decreases 4 hours after
TNF exposure. Function-blocking anti-TNF antibody reduces
Ki67 expression, showing that TNF promotes proliferation
in the epithelium. Together, these data show that BMAL1
regulates cell proliferation downstream of TNF, but the JNK
pathway is BMAL1-independent.
JUN target genes, in particular cell cycle and cell growth
regulators, were examined during TNF activation. BMAL1-/-
organoids have equivalent expression of the JUN target
genes CCND1 and CD44, but show differences in the regu-
lation of P21 (also called CDKN1A), a negative regulator of
proliferation (Figures 8B and 9A). Speciﬁcally, BMAL1þ/þ
organoids exhibit a TNF-dependent upregulation of P21
expression 4 hours after induction followed by a sharp
decrease at 8 hours. This response is completely absent in
BMAL1-/- organoids, which simply show a gradual decrease
in P21 expression. This suggests the timing of cell cycle
entry, during an inﬂammatory response, is altered when
BMAL1 is absent. However, the altered expression of cell
cycle regulators is not a general feature of BMAL1-/- orga-
noids, because these show equivalent expression of CCNB1,
CCNE1, E2F, and C-MYC (Figure 9B). We hypothesized that 1
function of BMAL1 is to produce a w4-hour delay in cell
cycle entry during the regenerative response to TNF.
To test this hypothesis, we assessed the number of
epithelial cells undergoing S-phase using EdU labeling in
BMAL1þ/þ versus BMAL1-/- organoids following TNF treat-
ment. BMAL1þ/þ organoids, whose P21 levels are higher,
show reduced S-phase entry compared with BMAL1-/-
organoids, whose levels of P21 are lower at this time
(Figure 8C). To further assess the impact of TNF on cell
cycle dynamics, we crossed the FUCCI2 cell cycle reporter
strain,52 which marks cells in G1 (RFP) and S/G2/M (GFP),
on the BMAL1 background. We generated organoids from
the BMAL1þ/þ, FUCCI2þ/- versus BMAL1-/-, FUCCI2þ/- mice
and tested their response to TNF treatment. Consistent with
their increase in S-phase entry, BMAL1-/- organoid cells
show a decrease in G1 phase compared with BMAL1þ/þ
control animals (Figure 8D). These data show that 1 func-
tion of BMAL1 is to regulate the timing of cell proliferation
in response to inﬂammatory stress. Not only does the clock
regulate TNF expression itself (Figures 6A–C), but in
response to TNF, the circadian clock regulates the timing of
epithelial S-phase.
Discussion
We ﬁnd that the circadian clock is active in the intestinal
epithelium during normal and pathologic states. However,
these distinct physiological states exhibit differences in
circadian gene expression. Epithelial regeneration during
the gastrointestinal syndrome shows circadian rhythms in
proliferation, and cytokines and cell cycle regulators are
regulated by the core clock gene BMAL1. These outputs are
not present in the undamaged state, suggesting this pro-
gram is dynamically initiated during regeneration. Based on
these data, we propose a model of circadian clock function
in the small intestine in which the targets TNF and P21
cooperate to drive diurnal rhythms in cell production
(Figure 10).
Circadian Proliferation in the Intestinal Epithelium
The intestine has been reported to exhibit circadian
rhythms in its physiology, including 24-hour rhythms in
proliferation.7,25,26 However, we found no signiﬁcant
diurnal changes in mitosis under normal homeostatic con-
ditions in this tissue (Figure 1E). Similarly, early attempts to
ﬁnd circadian rhythms in the small intestine were also un-
successful.29,30,53 There are several possibilities to account
for these discrepancies. Previous studies that reported
circadian rhythms in mitoses25 may have sampled different
regions of the small intestine, which exhibit regional dif-
ferences in circadian clock activity.14 For instance, such
regions as the duodenum show very slight diurnal changes
in S-phase versus such regions as the ileum that show high-
amplitude changes.7 It is possible the regions we sampled
(ie, the duodenum and proximal jejunum) do not show high-
amplitude 24-hour changes under undamaged conditions.
Another possibility is that speciﬁc phases of the cell cycle
might be differentially regulated by the clock, or other fac-
tors, such as diet and/or microbiota, could also affect the
expression of intestinal rhythmicity.
Despite the absence of mitotic rhythms during normal
conditions, we ﬁnd strong diurnal variation in mitosis
during the regenerative response following irradiation
(Figure 1F). Because studies supporting7,25,26 and
refuting29,30,53 circadian rhythmicity in intestinal cell pro-
liferation have been published, it is also possible that an
additional factor contributes to these rhythms. Reports of
circadian rhythms in the digestive tract applied tritiated
thymidine to label cells undergoing S-phase.25,26 These
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experiments involved injecting animals over a 24-hour
timeline and collecting samples 1 hour after injection. To
avoid an injection-related stress response, we assayed the
cell cycle noninvasively by detecting M-phase using anti-
body to pHH3, and detected diurnal rhythms in cell pro-
duction during a pathologic state. We have previously
shown that proliferation in the Drosophila intestine is gated
by the circadian clock only during regeneration, and that
before damage no rhythms are detected.54 This bears a
similarity to our present results, and we thus suggest
physiological stresses drive and/or amplify circadian
rhythms in cell proliferation.
Circadian Control of the Cell Cycle
There is compelling evidence to link the cell cycle with
the circadian clock,10 and regulators, such as WEE1, have
been shown to be bona ﬁde clock targets in the liver.38 A
direct link between cell cycle regulation and the circadian
clock has yet to be established in the intestinal epithelium. A
recent study has shown that cell proliferation rhythms in
the colon can be changed by altering the timing of food
intake,31 suggesting the clock may not control the cell cycle
in intestinal epithelia directly. We ﬁnd that WEE1 is
arrhythmic during healing (Figure 6B), when proliferation is
rhythmic (Figure 2D), demonstrating that the cell cycle and
the clock are either not directly linked, or can be decoupled.
Our results support that the circadian clock controls the cell
cycle regulator P21, during the inﬂammatory response to
TNF. Twenty-four-hour rhythms in the expression of P21
have been observed in cancer patient colon biopsies
suggesting this ﬁnding may be conserved in mammals.55
In addition to these connections, we cannot discount
circadian control of the cell cycle through transcriptional or
posttranscriptional regulation of different genes involved in
proliferation. Genome-wide transcriptome and proteome
analysis of all cell cycle regulators in this tissue would
resolve this question, and the precise targeting of cell cycle
regulators by the circadian clock in the intestinal
epithelium.
Circadian Control of Cell Signaling
Genes involved in the immune response, such as TNF
and CCL2, exhibit diurnal rhythms during healing. In
particular, the TNF inﬂammatory cytokine exhibits diurnal
changes in the intestine (Figures 6A and B) and is rhyth-
mically expressed in organoid epithelia autonomously
(Figure 6C). TNF production has been shown to exhibit
circadian rhythms in a variety of tissues,42,43 and it is very
likely to be produced by the epithelium and its surrounding
cells. A recent study showed that the regulation of TNF
expression in the colon is disrupted in clock mutants
exposed to alcohol-induced injury.56 This suggests the role
of the clock in the regulation of these genes may be a gen-
eral feature in digestive tract pathology. Further work is
needed to resolve the complex interplay between clock-
regulated sources of the different cytokines that regulate
the digestive system.
Similar to our previous studies in Drosophila,54 prolif-
eration rhythms during regeneration involve signaling pro-
cesses. Overall, our results suggest that as epithelial cells
switch from a state of tissue maintenance to a state of
regeneration, the circadian clock regulates different target
genes. Such a process may involve the recruitment of tran-
scriptional regulators to work in conjunction with the genes
CLK and BMAL1, REV-ERBa, or RORa in the same cell.
Alternatively, context-dependent posttranscriptional mech-
anisms11,57 may alter transcriptional output in these cells
during regeneration.
The effect of cytokines on epithelial cell production is
particularly relevant in understanding how disease states,
such as inﬂammation and cancer, are related.58 TNF is of
particular importance and, consistent with our results, has
been recently reported to increase the proliferation of
intestinal organoids.59 TNF can activate both NFkB50 and
JNK51,60 pathways, both of which promote proliferation
and tumorigenesis of intestinal epithelia. We ﬁnd that TNF
is produced rhythmically by the intestinal epithelium
under clock control, and that the clock further regulates
the proliferation response to TNF. The DNA-binding activ-
ity of JUN has been observed to be circadian,46 consistent
with these ﬁndings. Our results showing the circadian clock
regulation of P21 are consistent with observations in the
circadian expression of P21 in human55 and zebraﬁsh61
Figure 10. A proposed model of circadian clock function
in the regenerating small intestinal epithelium. BMAL1
controls TNF and P21 during a pathologic state. TNF cytokine
signaling increases epithelial proliferation in epithelial pre-
cursors to replace damaged epithelial cells. Rhythms in TNF
production may arise from the epithelium but also are well
known to be rhythmically produced by the immune system
(see discussion). In epithelial cells, P21 response is under
clock control downstream of TNF to regulate diurnal rhythms
in cell production.
July 2017 BMAL1 and Intestinal Regeneration 111
cells, overall suggesting a conserved mechanism of cell
cycle control.
JNK signaling can enhance Wnt pathway activity in the
intestinal epithelium,51 and cJUN has also been shown to be
enriched in the LGR5þ intestinal stem cell population.62 NFkB
activation also enhances Wnt signaling and causes the
dedifferentiation of transit-amplifying cells into intestinal
stem cells.63 The rhythmic production of TNF in the epithe-
lium during the gastrointestinal syndrome could therefore
inﬂuence stem cell and transit-amplifying cells by boosting
Wnt signaling. Similar circadian clock activity in stem cells
has been documented in several systems.64 In intestinal
organoids, we ﬁnd that the BMAL1-/- epithelium shows de-
ﬁciencies in the expression of epithelial markers (Figure 5D).
In particular, a reduction in LYZ1 and LGR5 expression in
organoids may explain why the BMAL1-/- intestine shows a
slight reduction in crypt number (Figures 2A and 3A) and
LGR5 expression (Figure 3C) in vivo. LGR5þ intestinal stem
cells are intermingled with Paneth cells in a Wnt signaling
milieu, and a reduction in stem cell and Paneth cell markers
suggests a maintenance deﬁciency. Although these pheno-
types seem to be generally compensated during maintenance
in vivo (Figure 3) and in vitro (Figure 5E), the circadian clock
may play a role in epithelial Wnt signaling in certain physi-
ological contexts. While this study was under revision, it was
reported that Wnt signaling is regulated by the clock in in-
testinal organoids, caused by the expression of WNT3A by
Paneth cells.28 Circadian control of intestinal signaling path-
ways may be an important mechanism linking tissue ho-
meostasis with general physiology.
Circadian Rhythms in Disease
The health of shift-workers who undergo photoperiod
disruption is signiﬁcantly worsened,17–19 and our ﬁndings
that rhythmic gene expression is BMAL1-dependent shows
the circadian clock regulates important processes in the
pathologic state. This highlights the underappreciated role
of 24-hour timing in gastrointestinal illness, and future
studies need to be done to test connections between
photoperiod and disease etiology and progression. Although
our work has been carried out in LD photoperiod where
environmental light could induce diurnal changes that are
not a direct function of clock activity, because we observe
diurnal changes in the BMAL1þ/þ intestine that are not
present in BMAL1-/-, the effects we report are unlikely to be
a simple response to environmental change. Our data
highlight the importance of photoperiod on the mechanisms
underlying disease. Current treatment regimens may be able
to apply these and future insights from circadian biology.65
Moreover, it will be critical to account for circadian rhyth-
micity, and time-of-day dependency, in the use of animal
models to study the biology and treatment of gastrointes-
tinal disease.
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